550 Participants Needed

Risk Perception for Breast Cancer

Recruiting at 2 trial locations
CT
Overseen ByClinical Trials Referral Office
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how women of color perceive their risk of developing breast cancer. Researchers seek to learn how these women view their current and future chances of getting breast cancer and what factors might influence their understanding. Participants will complete surveys and may join interviews to share their thoughts. Women who self-identify as female, are between 18 and 50 years old, and have never had breast cancer are a good fit for this study.

As an unphased study, this trial offers participants a unique opportunity to contribute to valuable research that could shape future breast cancer education and prevention strategies.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to understand how women of color perceive their cancer risk, which is a crucial step toward improving health outcomes in these communities. Unlike traditional treatments that focus solely on medical interventions, this research emphasizes patient perspectives through surveys and potential interviews. By exploring these unique insights, the trial could lead to more personalized and effective communication strategies, ultimately empowering women of color to make informed health decisions and potentially enhancing early detection and prevention efforts.

Who Is on the Research Team?

JD

Jessica D. Austin, PhD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

Inclusion Criteria

You identify as a woman.
You are between 25 and 50 years old.
You have no prior documentation of breast cancer.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Survey and Interview

Participants complete a survey and may participate in an interview to assess their perception of breast cancer risk

Baseline (at enrollment)

Follow-up

Participants are monitored for any changes in risk perception and understanding after the initial survey and interview

4 weeks

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Health Services ResearchExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+